We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $1.69M | 0.02% |
+60,356
| New | +$1.66M |
|
552
Paylocity
PCTY
$6.71B
| $1.68M | 0.02% |
+17,920
| New | +$1.7M |
|
553
Selective Insurance
SIGI
$5.74B
| $1.68M | 0.02% |
22,428
+10,060
| +81% | +$716K |
|
554
DTE Energy
DTE
$31.1B
| $1.67M | 0.02% |
15,381
-352
| -2% | -$37.8K |
|
555
Crane NXT
CXT
$3.04B
| $1.67M | 0.02% |
57,465
| – | – |
|
556
HCA Healthcare
HCA
$84.8B
| $1.66M | 0.02% |
12,260
+1,250
| +11% | +$158K |
|
557
CSX Corp
CSX
$98.6B
| $1.64M | 0.02% |
63,750
-180,330
| -74% | -$4.65M |
|
|
CXP
558
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.64M | 0.02% |
79,168
-2,611
| -3% | -$57.9K |
|
559
Universal Insurance Holdings
UVE
$1.16B
| $1.63M | 0.02% |
58,349
-57,610
| -50% | -$1.69M |
|
560
Travelzoo
TZOO
$103M
| $1.62M | 0.02% |
105,192
+18,833
| +22% | +$317K |
|
561
National Beverage
FIZZ
$2.87B
| $1.62M | 0.02% |
72,720
-25,780
| -26% | -$663K |
|
562
Daktronics
DAKT
$941M
| $1.62M | 0.02% |
262,051
+6,550
| +3% | +$45.6K |
|
563
Visa
V
$677B
| $1.6M | 0.02% |
+9,230
| New | +$1.51M |
|
|
HTB
564
HomeTrust Bancshares
HTB
$818M
| $1.59M | 0.02% |
63,244
+5,960
| +10% | +$150K |
|
565
Healthcare Realty
HR
$7.42B
| $1.54M | 0.02% |
+56,300
| New | +$1.59M |
|
566
Ubiquiti
UI
$31.8B
| $1.54M | 0.02% |
11,740
-10,720
| -48% | -$1.55M |
|
567
LifeVantage
LFVN
$82.4M
| $1.53M | 0.02% |
117,545
+80,199
| +215% | +$953K |
|
|
ITCI
568
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.51M | 0.02% |
116,684
+7,100
| +6% | +$91.1K |
|
|
AFI
569
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.51M | 0.02% |
153,084
-34,315
| -18% | -$425K |
|
|
NCI
570
DELISTED
Navigant Consulting, Inc.
NCI
| $1.5M | 0.02% |
64,652
-3,300
| -5% | -$73K |
|
571
Kforce
KFRC
$983M
| $1.48M | 0.02% |
42,166
+4,120
| +11% | +$148K |
|
|
UCB
572
United Community Banks
UCB
$4.22B
| $1.48M | 0.02% |
51,740
+9,200
| +22% | +$251K |
|
|
FNHC
573
DELISTED
FedNat Holding Company Common Stock
FNHC
| $1.48M | 0.02% |
103,383
+1,511
| +1% | +$23K |
|
|
MODV
574
DELISTED
ModivCare
MODV
| $1.47M | 0.02% |
25,656
+10,554
| +70% | +$684K |
|
575
Community Trust Bancorp
CTBI
$1.38B
| $1.47M | 0.02% |
34,724
+3,017
| +10% | +$125K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.